Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a member is changing plans or managing a new health condition, the experience should feel guided rather than overwhelming.
News|Articles|December 31, 2024
Top 5 Women’s Health Articles of 2024
Author(s)MHE Staff
Take a look at this year’s top articles — one showcasing enhanced weight loss through Semaglutide use in post-menopausal women on hormonal therapy.
Advertisement
- Semaglutide Shows Enhanced Weight Loss in Postmenopausal Women on Hormone Therapy
During menopause, up to 70% of women experience weight gain due to aging, estrogen decline, a decrease in energy and a decrease in spontaneous physical activity energy.Read here - Postmenopausal Women Who Use Hormone Therapy Biologically Younger
Women with disadvantaged backgrounds may also benefit more than women with a higher socioeconomic status, study results show.Read her e
- Menopause Increases Brain Estrogen Receptors, Affecting Memory and Mood
According to a new study, it was found that higher estrogen receptor density could tell whether a woman is premenopausal or postmenopausal, and that it’s related to lower memory scores and mood and cognitive issues in postmenopausal women.Read here - Poor Sleep in Midlife Linked to Higher Cardiovascular Disease Risk for Women
Up to 50% of women have reported that they struggle with sleep issues in midlife, while CVD stands as the main cause of death in women.Read here - The IRA’s Impact on Women in Medicare
In 2025, the out-of-pocket cap and other Part D related provisions in the Inflation Reduction Act are projected to save women in Medicare an average of 28% in out-of-pocket costs, according to a new analysis from the Office of the Assistant Secretary for Planning and Evaluation.Read here
Advertisement
Related to this article
Pretax adjusted income from operations from Express Scripts, Cigna's pharmacy benefit manager, fell by 21.5% compared with the third quarter of 2025, while income from operations of its specialty drug business jumped by 15%.
Annesha White, Pharm.D., M.S., Ph.D., and Fredrick Manasseh, Pharm.D., MBA, BCGP, explain where AI helps managed care pharmacy, where bias creeps in and what skills pharmacists need to oversee it.
Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection monitoring required.
Value-based care has scored some cost-saving successes, says Christopher Stanley, M.D., MBA, president of Henry Ford Health's Populance. Health systems that build their own value-based care strategy, rather than adopting particular models one by one, will be in the best position to succeed, he says.
The second half of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.
The first part of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.
Christopher Stanley, M.D., MBA, on the early population health wins of Henry Ford Health's Populance
Unifying care management doubled patient outreach with the same staff, and virtual physical therapy is cutting costs, says Populance's Christopher Stanley, M.D.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
WHO adds two Bundibugyo vaccines to Ebola trial in the DRC
2
Christopher Stanley, M.D., MBA, on the early population health wins of Henry Ford Health's Populance
3
Christopher Stanley, M.D., MBA, on why Henry Ford Health's Populance is pivoting inward
4
On Populance's pivot to internal customers, some early wins and the current state of value-based care | A conversation with Christopher Stanley, M.D.. MBA
5